...
首页> 外文期刊>Pathology Research and Practice >Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
【24h】

Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.

机译:甲状腺乳头状癌和滤泡性肿瘤nm23蛋白表达的免疫组织化学分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

INTRODUCTION: We aimed at assessing the significance of nm23 gene expression in papillary and follicular carcinomas, the two most common differentiated thyroid carcinomas. MATERIALS AND METHODS: During a cross-sectional study, 173 paraffin blocks, including 131 papillary thyroid carcinomas, 12 follicular carcinomas and 30 follicular adenomas were stained with nm23 marker by immunohistochemistry method. Cytoplasmic staining in more than 10% of the tumor cells was considered as positive, and alpha<0.05 was established as the level of statistical significance for the evaluation of the correlation between nm23 expression and age, sex, tumor size, vascular /capsular invasion and lymph node involvement. RESULTS: nm23 was positive in 40% of the follicular adenoma, 67.2% of the papillary carcinoma and 66.7% of the follicular carcinoma. p value was more than 0.05 in the assessment of the relationship between nm23 and all of the above-mentioned parameters in differentiated thyroid carcinomas. nm23 expression didnot significantly differentiate between follicular adenoma and carcinoma. CONCLUSION: According to our results, there is no relationship between nm23 immunoreactivity and age or sex of the patients. Also, nm23 cannot be considered as a useful marker for the evaluation of invasion in differentiated thyroid carcinomas or in distinctions between follicular adenoma and carcinoma.
机译:简介:我们旨在评估nm23基因表达在乳头状和滤泡状癌中的重要性,这是两种最常见的分化型甲状腺癌。材料与方法:在一项横断面研究中,使用nm23标记物通过免疫组织化学方法对173个石蜡块(包括131个甲状腺乳头状癌,12个滤泡癌和30个滤泡腺瘤)进行了染色。超过10%的肿瘤细胞的细胞质染色被认为是阳性的,并建立了<0.05作为统计显着性水平,用于评估nm23表达与年龄,性别,肿瘤大小,血管/囊膜浸润和淋巴结受累。结果:nm23阳性的滤泡状腺瘤占40%,乳头状癌占67.2%,滤泡状癌占66.7%。在评估分化型甲状腺癌中nm23与所有上述参数之间的关系时,p值大于0.05。 nm23表达在滤泡性腺瘤和癌之间没有显着区别。结论:根据我们的结果,nm23免疫反应性与患者的年龄或性别之间没有关系。同样,nm23不能被认为是评估分化型甲状腺癌或滤泡性腺瘤与癌性之间的浸润的有用标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号